Helsing P - Search Results

1

Malignant melanoma--diagnosis, treatment and follow-up in Norway.

Geisler J, Bachmann IM, Nyakas M, Helsing P, Fjøsne HE, Mæhle LO, Aamdal S, Eide NA, Svendsen HL, Straume O, Robsahm TE, Jacobsen KD, Akslen LA. Geisler J, et al. Among authors: helsing p. Tidsskr Nor Laegeforen. 2013 Oct 29;133(20):2154-9. doi: 10.4045/tidsskr.12.1416. Tidsskr Nor Laegeforen. 2013. PMID: 24172628 Free article. Review. English, Norwegian.

2

Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma.

Robsahm TE, Helsing P, Svendsen HL, Veierød MB. Robsahm TE, et al. Among authors: helsing p. Acta Derm Venereol. 2021 Apr 12;101(4):adv00427. doi: 10.2340/00015555-3782. Acta Derm Venereol. 2021. PMID: 33686445 Free PMC article.

3

Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality.

Robsahm TE, Helsing P, Veierød MB. Robsahm TE, et al. Among authors: helsing p. Cancer Med. 2015 Mar;4(3):472-80. doi: 10.1002/cam4.404. Epub 2015 Jan 26. Cancer Med. 2015. PMID: 25620456 Free PMC article.

4

Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location.

Helsing P, Robsahm TE, Vos L, Rizvi SM, Akslen LA, Veierød MB. Helsing P, et al. J Am Acad Dermatol. 2016 Nov;75(5):975-982.e2. doi: 10.1016/j.jaad.2016.06.048. Epub 2016 Aug 18. J Am Acad Dermatol. 2016. PMID: 27546291

5

Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study.

Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE. Veierød MB, et al. Among authors: helsing p. J Am Acad Dermatol. 2018 Jul;79(1):118-125.e1. doi: 10.1016/j.jaad.2018.03.023. Epub 2018 Mar 23. J Am Acad Dermatol. 2018. PMID: 29580861

6

[Treatment of malignant melanoma].

Helsing P. Helsing P. Tidsskr Nor Laegeforen. 2004 Nov 18;124(22):2916-7. Tidsskr Nor Laegeforen. 2004. PMID: 15550966 Free article. Norwegian.

7

High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry.

Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB. Robsahm TE, et al. Among authors: helsing p. Clin Epidemiol. 2018 May 9;10:537-548. doi: 10.2147/CLEP.S151246. eCollection 2018. Clin Epidemiol. 2018. PMID: 29780262 Free PMC article.

8

Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas.

Helsing P, Nymoen DA, Ariansen S, Steine SJ, Maehle L, Aamdal S, Langmark F, Loeb M, Akslen LA, Molven A, Andresen PA. Helsing P, et al. Genes Chromosomes Cancer. 2008 Feb;47(2):175-84. doi: 10.1002/gcc.20518. Genes Chromosomes Cancer. 2008. PMID: 18023021

9

[Malignant melanoma. Diagnosis, treatment and follow-up].

Helsing P. Helsing P. Tidsskr Nor Laegeforen. 1997 Sep 10;117(21):3107-8. Tidsskr Nor Laegeforen. 1997. PMID: 9381447 Norwegian.

10

Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.

Roscher I, Falk RS, Vos L, Clausen OPF, Helsing P, Gjersvik P, Robsahm TE. Roscher I, et al. Among authors: helsing p. JAMA Dermatol. 2018 Apr 1;154(4):428-434. doi: 10.1001/jamadermatol.2017.6428. JAMA Dermatol. 2018. PMID: 29516080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page